— Know what they know.
Not Investment Advice

CTTH OTC

CTT Pharmaceutical Holdings, Inc.
1W: +1.9% 1M: +12.5% 3M: -23.6% YTD: -9.0% 1Y: -5.0% 3Y: +436.6% 5Y: -27.5%
$0.06
-0.00 (-3.51%)
 
Weekly Expected Move ±11.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 54 · $3.3M mcap · 57M float · 0.052% daily turnover · Short 45% of daily vol

Balance Sheet Trends

Total Assets
$73K -7.9% ▼
5Y CAGR: -33.8%
Total Liabilities
$41K +111.8% ▲
5Y CAGR: -38.1%
Shareholders Equity
$32K -46.4% ▼
5Y CAGR: -23.5%
Cash & Investments
$114 +0.0% ▲
5Y CAGR: -80.3%
Total Debt
$17K +55.6% ▲
Net Debt
$17K +54.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$202K$102K$8K$0$114
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$202K$102K$8K$0$114
Net Receivables$174K$6K$44$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$376K$108K$8K$0$114
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$86K$79K$73K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$86K$79K$73K
Total Assets$376K$108K$94K$79K$73K
— Liabilities —
Accounts Payable$663K$102K$0$0$0
Short-Term Debt$0$0$0$0$17K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$5K$8K$24K
Total Current Liabilities$663K$102K$5K$8K$41K
Long-Term Debt$0$0$0$11K$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$11K$0
Total Liabilities$663K$102K$5K$19K$41K
— Equity —
Common Stock$329K$332K$302K$386K$5K
Retained Earnings-$7M-$7M-$7M-$7M-$7M
Accumulated OCI$2K$2K$2K$2K$0
Total Stockholders Equity-$287K$5K$89K$60K$32K
Total Liabilities & Equity$376K$108K$94K$79K$73K
— Key Metrics —
Total Debt$0$0$0$11K$17K
Net Debt-$202K-$102K-$8K$11K$17K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms